✦ LIBER ✦

KRAS status predicts response to cetuximab in mCRC

Book ID: 120843125
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2008
Weight: 152 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200816410-00018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

KRAS Mutation Status Is Predictive of Re

KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer

✍ Lievre, A. 📂 Article 📅 2006 🏛 American Association for Cancer Research 🌐 English ⚖ 215 KB

KRAS predictive of response to cetuximab

KRAS predictive of response to cetuximab in colorectal cancer

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

KRAS status as a predictor of response t

KRAS status as a predictor of response to EGFR inhibitors in mCRC

✍ Jame Abraham 📂 Article 📅 2008 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 112 KB

EGF61 Polymorphism Predicts Complete Pat

EGF61 Polymorphism Predicts Complete Pathologic Response to Cetuximab-Based Chemoradiation Independent of KRAS Status in Locally Advanced Rectal Cancer Patients

✍ Hu-Lieskovan, S.; Vallbohmer, D.; Zhang, W.; Yang, D.; Pohl, A.; Labonte, M. J.; 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 241 KB

Tumour gene expression predicts response

Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer

✍ Baker, J B; Dutta, D; Watson, D; Maddala, T; Munneke, B M; Shak, S; Rowinsky, E 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 640 KB

Wild-type KRAS and BRAF could predict re

Wild-type KRAS and BRAF could predict response to Cetuximab in Chinese colorectal cancer patients

✍ Jing Gao; Ting-ting Wang; Jing-wei Yu; Yan-yan Li; Lin Shen 📂 Article 📅 2011 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 692 KB